UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                   FORM 10-Q/A

              [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                  For the Quarterly Period Ended June 30, 1999

                                       OR

              [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


                         Commission file number 0-17019

                               ANGEION CORPORATION
             (Exact name of registrant as specified in its charter)

               Minnesota                             41-1579150
       (State of Incorporation)           (IRS Employer Identification No.)


7601 Northland Drive, Brooklyn Park, MN              55428-1088
        (Address of principal                        (Zip Code)
          executive offices)


                                 (612) 315-2000
                               (Telephone number)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                                 YES _X_ NO ___

            Common stock, par value $.01 per share: 4,009,659 shares
                        outstanding as of August 12, 1999


                                     Page 1
<PAGE>


ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K.

      (a)   Exhibits

            Item No.    Item
            --------    ----

            3.1         Articles of Merger, including Amended and Restated
                        Articles of Incorporation (incorporated by reference to
                        Exhibit 3A contained in the Company's Registration
                        Statement on Form 8-A (File No. 0-17019)).

            3.2         Amendment to the Company's Amended and Restated Articles
                        of Incorporation (incorporated by reference to Exhibit
                        4.3 contained in the Company's Registration Statement on
                        Form S-3 (File No. 333-36005)).

            3.3         Amendment to the Company's Amended and Restated Articles
                        of Incorporation (incorporated by reference to Exhibit
                        4.4 to the Company's Registration Statement on Form S-3
                        (File No. 333-50557)).

            3.4         Amended Bylaws (incorporated by reference to Exhibit 4.2
                        contained in the Company's Registration Statement on
                        Form S-3 (File No. 333-04993)).

            4.1         Warrant dated as of March 12, 1999 in the name of
                        Synthelabo to purchase 9,090,171 shares of Common Stock.

            4.2         Warrant dated as of March 12, 1999 in the name of
                        Synthelabo to purchase 5,405,405 shares of Common Stock.

            10.1        Letter Amendment dated as of March 12, 1999 to the
                        Amended and Restated Investment and Master Strategic
                        Relationship Agreement dated as of October 9, 1997
                        between the Company and Synthelabo.

            10.2        Withdrawal Agreement dated as of May 11, 1999 by and
                        between the Company and ELA Medical, Inc.

            10.3        Amendment and Termination of Implantable Cardioverter
                        Defibrillator Product Manufacturing and Supply Agreement
                        dated as of May 11, 1999 by and between the Company and
                        ELA* Angeion, LLC.

            10.4        Amendment of Implantable Cardioverter Defibrillator
                        Product Manufacturing and Supply Agreement dated May 11,
                        1999 by and between the Company and ELA Medical, S. A.

            10.5        Amendment to Investment and Master Strategic
                        Relationship Agreement dated as of May 11, 1999 between
                        the Company and Synthelabo

            10.6        Settlement Agreement and Mutual Release dated as of May
                        11, 1999 by and between the Company, ELA Medical, Inc.,
                        and ELA Medical, S. A.

            12          Computation of ratio of earnings to fixed charges.

            27          Financial Data Schedule.


                                     Page 2
<PAGE>


                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                    ANGEION CORPORATION


Dated: October 6, 1999              By:  /s/ James B. Hickey, Jr.
                                    ----------------------------------------
                                         James B. Hickey, Jr.
                                         President and Chief Executive Officer
                                         (principal executive officer and acting
                                          principal financial officer)


                                     Page 3
<PAGE>


                                  EXHIBIT INDEX

     Exhibit     Description of Document                        Method of Filing
     -------     -----------------------                        ----------------

     3.1         Articles of Merger, including Amended and      Incorporated by
                 Restated Articles of Incorporation             Reference
                 (incorporated by reference to Exhibit 3A
                 contained in the Company's Registration
                 Statement on Form 8-A (File No. 0-17019)).

     3.2         Amendment to the Company's Amended and         Incorporated by
                 Restated Articles of Incorporation             Reference
                 (incorporated by reference to Exhibit 4.3
                 contained in the Company's Registration
                 Statement on Form S-3 (File No. 333-36005)).

     3.3         Amendment to the Company's Amended and         Incorporated by
                 Restated Articles of Incorporation             Reference
                 (incorporated by reference to Exhibit 4.4 to
                 the Company's Registration Statement on Form
                 S-3 (File No. 333-50557)).

     3.4         Amended Bylaws (incorporated by reference to   Incorporated by
                 Exhibit 4.2 contained in the Company's         Reference
                 Registration Statement on Form S-3 (File No.
                 333-04993)).

      4.1        Warrant dated as of March 12, 1999 in the      Previously Filed
                 name of Synthelabo to purchase 9,090,171
                 shares of Common Stock.

      4.2        Warrant dated as of March 12, 1999 in the      Previously Filed
                 name of Synthelabo to purchase 5,405,405
                 shares of Common Stock.

      10.1       Letter Amendment dated as of March 12, 1999    Previously Filed
                 to the Amended and Restated Investment and
                 Master Strategic Relationship Agreement
                 dated as of October 9, 1997 between the
                 Company and Synthelabo.

      10.2       Withdrawal Agreement dated as of May 11,       Filed herewith
                 1999 by and between the Company and ELA
                 Medical, Inc.

      10.3       Amendment and Termination of Implantable       Filed herewith
                 Cardioverter Defibrillator Product
                 Manufacturing and Supply Agreement dated as
                 of May 11, 1999 by and between the Company
                 and ELA* Angeion, LLC.

      10.4       Amendment of Implantable Cardioverter          Filed herewith
                 Defibrillator Product Manufacturing and
                 Supply Agreement dated May 11, 1999 by and
                 between the Company and ELA Medical, S. A.

      10.5       Amendment to Investment and Master Strategic   Filed herewith
                 Relationship Agreement dated as of May 11,
                 1999 between the Company and Synthelabo

      10.6       Settlement Agreement and Mutual Release        Filed herewith
                 dated as of May 11, 1999 by and between the
                 Company, ELA Medical, Inc., and ELA Medical,
                 S. A.

      12         Computation of ratio of earnings to fixed      Previously Filed
                 charges.

      27         Financial Data Schedule.                       Previously Filed


                                     Page 4